Physician

Daniel Andrew Beggs, M.D.

According to 2025 Medicare claims, Daniel Beggs, M.D. (NPI: 1689615734) practices gastroenterology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is BSA AMARILLO DIAGNOSTIC CLINIC INC (NPI: 1134559826; TIN: 464065241) and primary practice location at 79106-1701. Beggs is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974), CVS ACO (ACO ID: A5407), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Beggs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 882 traditional Medicare patients, billed 58,808 HCPCS/CPT codes, and received $446,120 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,989 prescription claims across 572 beneficiaries totaling $1,833,567 in drug costs, led by Skyrizi On-Body (Risankizumab-Rzaa). DME data shows 209 claims. Open Payments data shows 59 records totaling $920. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $218,723 to $446,120. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,167,484 and ending at $1,833,567. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	875	6,927	$218,723
2016	864	8,471	$200,441
2017	883	14,421	$263,303
2018	871	34,390	$426,539
2019	894	42,012	$426,839
2020	836	52,935	$564,447
2021	926	57,484	$582,715
2022	838	50,925	$539,634
2023	803	52,428	$422,326
2024	882	58,808	$446,120

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	523	2,670	$2,167,484
2016	569	2,829	$1,059,786
2017	623	2,938	$1,408,190
2018	662	3,094	$1,297,330
2019	677	3,187	$1,584,445
2020	501	2,999	$1,157,676
2021	565	3,156	$1,563,298
2022	551	2,919	$1,641,874
2023	561	2,852	$1,825,203
2024	572	2,989	$1,833,567

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	353	$187,391
2019	N/R	443	$239,363
2020	N/R	262	$140,003
2021	N/R	249	$127,222
2022	N/R	236	$122,639
2023	N/R	212	$136,970
2024	N/R	209	$151,636

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	247	248	$197
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	172	212	$81
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	113	115	$48
36415	Insertion of needle into vein for collection of blood sample	136	198	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	120	203	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi On-Body	Risankizumab-Rzaa	15	840	$315,892
Humira(Cf) Pen	Adalimumab	42	1,232	$313,835
Humira Pen	Adalimumab	18	654	$228,205
Zenpep	Lipase/Protease/Amylase	13	404	$60,322
Linzess	Linaclotide	85	3,120	$54,815

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4199	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix	N	N/R	50	$115,356
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	53	$23,676
B4224	Parenteral nutrition administration kit, per day	N	N/R	53	$9,548
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	53	$3,057

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$920	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Andrew Beggs, M.D.?

Tedicare shows public-source Medicare data for Daniel Andrew Beggs, M.D. (NPI 1689615734), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Andrew Beggs, M.D. have ACO affiliation data?

Daniel Andrew Beggs, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), CVS ACO (MSSP, ACO ID A5407), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Daniel Andrew Beggs, M.D.?

Daniel Andrew Beggs, M.D. is linked to BSA AMARILLO DIAGNOSTIC CLINIC INC (billing NPI 1134559826) in the available physician profile data.

Does Daniel Andrew Beggs, M.D. have Open Payments data?

Daniel Andrew Beggs, M.D. has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.